Oxaprozin and Diflunisal Interaction

Understanding the Oxaprozin and Diflunisal Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Oxaprozin belongs to the Nonsteroidal Anti-Inflammatory Drug (NSAID) class and Diflunisal belongs to the Nonsteroidal Anti-Inflammatory Drug (NSAID) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Taking two similar pain relievers together increases the risk of stomach damage without providing any extra pain relief. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Oxaprozin has 15 total documented interactions on file in this dataset, and Diflunisal has 17. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Avoid taking these two medications at the same time to prevent unnecessary damage to your digestive system. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Oxaprozin or Diflunisal based on a web page, speak with your prescriber or pharmacist before making any change.